Village Fertility Pharmacy, Inc.

Village Fertility Pharmacy, Inc. specializes in providing pharmaceutical services tailored for reproductive health, focusing on enhancing the experience and outcomes for patients undergoing fertility treatments. Founded in 1986, Village Fertility Pharmacy, Inc. is headquartered in Waltham, US, and offers specialized pharmacy services for fertility treatments.

The CEO is Richard Burkett, who has a background in pharmacy management and has held leadership roles in similar healthcare enterprises. The company has successfully completed five deals, with the most recent deal occurring on August 8, 2024, when Apothecary by Design exited its stake in the company. Village Fertility Pharmacy, Inc. delivers tailored pharmaceutical services specifically designed for fertility treatments.

Its offerings include personalized medication management, compounded medications, and patient support services aimed at enhancing the fertility treatment journey. The company focuses on addressing specific needs in the reproductive health sector, ensuring patients receive tailored care throughout their treatment process. The company operates on a subscription-based revenue model, allowing clients to access its specialized services for fertility treatments. This approach enables a consistent revenue stream, with pricing structured to cater to various service levels depending on client needs.

The company collaborates with healthcare providers to enhance service integration, targeting a broad client base that includes individuals and fertility clinics. Village Fertility Pharmacy, Inc. is working on launching new services designed to expand its support for patients undergoing fertility treatments in 2025. The company aims to penetrate additional markets within North America and Europe by mid-2024, leveraging recent funding from the exit of Apothecary by Design to enhance its service offerings and expand operational capabilities.